Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 238.368B	--
Feb 20, 2025	2025/Q3	-- / 278.927B	--
Nov 15, 2024	2025/Q2	236.503B / 240.047B	--
Aug 15, 2024	2025/Q1	243.236B / 247.451B	--
May 14, 2024	2024/Q4	221.874B / 219.804B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 238.368B--

Feb 20, 20252025/Q3-- / 278.927B

Alibaba Group Q4 FY2024 earnings conference call

Feb 20 06:30

Book

Nov 15, 20242025/Q2236.503B / 240.047B

Alibaba Group Q2 FY2025 earnings conference call

Nov 15 06:30

Replay

Aug 15, 20242025/Q1243.236B / 247.451B

Alibaba Group Q1 FY2025 earnings conference call

Aug 15 06:30

Replay

May 14, 20242024/Q4221.874B / 219.804B

Alibaba Group Q4 FY2024 earnings conference call

May 14 06:30

Replay

Unlock Free Earnings Estimates

Open Account

Alibaba Earnings Reports

6-K: Report of foreign private issuer (related to financial reporting)

Nov 18, 2024 06:24 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 15, 2024 16:03 ET

6-K: Report of foreign private issuer (related to financial reporting)

Aug 23, 2024 07:11 ET

6-K: Report of foreign private issuer (related to financial reporting)

Aug 15, 2024 16:02 ET

Trending Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Feb 19, 2025

Strong Buy

Buy
87.50%
Hold
12.50%
Sell
0.00%

Price Target

No Data